Evenden J L
Preclinical Research and Development, Astra Arcus, Södertälje, Sweden.
Psychopharmacology (Berl). 1999 Oct;146(4):422-31. doi: 10.1007/pl00005487.
The serotonergic systems have been implicated in the pathological impulsive behaviour on the basis of both clinical and preclinical data. However, impulsivity is probably made up of several independent factors, and the involvement of the diverse regulatory mechanisms of the serotonergic systems has not been widely studied.
The influence of a range of serotonergic agents on impulsivity was examined using a procedure designed to test the dimension of impulsivity termed "reflection-impulsivity" in rats.
An operant procedure was used in which the need to wait before responding was made explicit by using a signal which increased in predictive value the longer the subject waited before responding. First, the rats learned that a light signal indicated the availability of a food reinforcer if one of two levers was pressed. In the test procedure, on each trial, when the light was turned on it was only 50% likely to indicate the "correct" lever. After a brief interval it was turned off and on again, this time with a slightly higher probability (>50%) of indicating the correct lever. Over a period of a few seconds the probability that the light indicated the correct lever increased to almost 100%. Thus a quick response to the light would result in many errors, whereas a slow response could always result in food delivery. Once trained the rats were treated with a series of drugs: citalopram, (selective serotonin reuptake inhibitor), p-chloramphetamine (PCA, serotonin releaser), 8-OH-DPAT (5-HT(1A) agonist), RU24969 (primarily a 5-HT(1B) receptor agonist), DOI, (5-HT(2) agonist), WAY-100,635 (5-HT(1A) antagonist), ritanserin (5-HT(2) antagonist), and MDL-72222, (5-HT(3) antagonist).
Of the test compounds, PCA, DOI and 8-OH-DPAT increased reaction times, whereas ritanserin reduced them. Citalopram and WAY-100,635 had no significant effects, RU-24969 appeared to disrupt responding, and MDL-72222 reduced premature responses and the number of short reaction times.
Since agonists at the 5-HT(1A) and 5-HT(2) receptors both reduced impulsivity in this procedure, these data suggest that serotonin may promote "reflection" in this procedure via stimulation of these receptor subtypes.
基于临床和临床前数据,血清素能系统与病理性冲动行为有关。然而,冲动性可能由几个独立因素构成,血清素能系统的多种调节机制的参与尚未得到广泛研究。
使用一种旨在测试大鼠中称为“反射性冲动性”的冲动维度的程序,研究一系列血清素能药物对冲动性的影响。
采用一种操作性程序,通过使用一种信号来明确做出反应前需要等待的时间,该信号在受试者做出反应前等待的时间越长,其预测价值就越高。首先,大鼠学会如果按下两个杠杆中的一个,光信号表示有食物强化物。在测试程序中,每次试验时,当灯亮起时,它只有50%的可能性指示“正确”的杠杆。经过短暂间隔后,灯再次关闭并重新亮起,这次指示正确杠杆的概率略高(>50%)。在几秒钟的时间内,灯指示正确杠杆的概率增加到几乎100%。因此,对光的快速反应会导致许多错误,而缓慢反应总能导致食物供应。大鼠一旦训练完成,就用一系列药物进行处理:西酞普兰(选择性血清素再摄取抑制剂)、对氯苯丙胺(PCA,血清素释放剂)、8-羟基二丙胺基四氢萘(8-OH-DPAT,5-羟色胺1A受体激动剂)、RU24969(主要是5-羟色胺1B受体激动剂)、DOI(5-羟色胺2激动剂)、WAY-100635(5-羟色胺1A拮抗剂)、利坦色林(5-羟色胺2拮抗剂)和MDL-72222(5-羟色胺3拮抗剂)。
在测试化合物中,PCA、DOI和8-OH-DPAT增加了反应时间,而利坦色林减少了反应时间。西酞普兰和WAY-100635没有显著影响,RU-24969似乎扰乱了反应,MDL-72222减少了过早反应和短反应时间的数量。
由于5-羟色胺1A和5-羟色胺2受体激动剂在此程序中均降低了冲动性,这些数据表明血清素可能通过刺激这些受体亚型在此程序中促进“反射”。